(Bloomberg) — Madrigal Pharmaceuticals Inc. shares surged 268%, adding about $2.9 billion to its market value, after a late-stage clinical trial of its drug candidate met the main goals in patie...
Tag: Madrigal
Madrigal Pharmaceuticals Stock Triples with 200% Hike on Test Results
With the FIFA season finale here’s a winner in surging as Madrigal pharmaceuticals stock price skyrocketed after its final phase study hit its goal. MDGL stock price has more than tripled as soon as M...
Viking Therapeutics’ stock rallies after Madrigal shares positive data about its liver drug
Shares of Viking Therapeutics Inc. VKTX, +77.61% jumped 55% in premarket trading on Monday after a company that is also developing a selective thyroid hormone receptor beta agonist as a treatment for ...